Fast Biopharma Ltd

#09981769 Active

FasT Biopharma is dedicated to developing innovative therapeutics that prevent cell death, targeting Fas ligand to combat diseases such as cancer, diabetes, and viral infections. Their breakthrough therapies aim to improve patient outcomes by blocking unwanted apoptosis.

Founded: 2 Feb 2016
Industries:
72110 - Research and experimental development on biotechnology
Location: Watlington

Products & Services

• apoptosis
• biopharma
• biotechnology
• cell death
• fas ligand
• fas ligand inhibitors
• health care
• pharmaceutical
• therapeutics
• therapeutics
• therapeutics development

Financial Snapshot

Last accounts made up to 31 Jan 2025
Next accounts due 31 Oct 2026 (11 months)
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →

People

Officers
2
Shareholders
5
Controllers (PSC)
2
Peter David Davis
Director • British • Lives in United Kingdom • Born in Aug 1956
David John Chaplin
Director • British • Lives in England • Born in Jan 1956

Registered Office Address

10 Aston Park

Aston Rowant

Watlington

OX49 5SW

United Kingdom

Basic Information

LTD
2 Feb 2016
ENGLAND WALES
Yes

Industry Classification

72110

Company Attributes

N/A
N/A
N/A
N/A

Summary

5
Officers
2
PSCs
0
Filings